Coupled plasma filtration adsorption in the treatment of septic shock

Contributions to Nephrology

Volumn 132, Issue , 2001, Pages 383-390

  Brendolan, Alessandra ^a   Bellomo, Rinaldo ^b   Tetta, Ciro ^c,d   Piccinni, Pasquale ^a   Digito, Antonio ^a   Wratten, Mary Louise ^c   Dan, Maurizio ^a   Irone, Marco ^a   La Greca, Giuseppe ^b   Inguaggiato, Paola ^c   Ronco, Claudio ^a  

^a SAN BORTOLO HOSPITAL   (Italy)

^b AUSTIN HEALTH   (Australia)

^c Clinical and Laboratory Research Department   (Italy)

^d Cyberonics Inc   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

ADSORPTION; CRITICAL ILLNESS; HEMOFILTRATION; HUMAN; REVIEW; SEPTIC SHOCK;

ADSORPTION; CRITICAL ILLNESS; HEMOFILTRATION; HUMANS; SHOCK, SEPTIC;

EID: 0035532703     PISSN: 03025144     EISSN: None     Source Type: Book Series    
DOI: 10.1159/000060107     Document Type: Article

References (30)

1. Beaman M, Turney JH, Rodger RSC, McGonigle RJS, Adu D, Michael J: Changing pattern of acute renal failure. Q J Med 1987;237:15-23.
2. Liano F, Junco E, Pascual J, Madero R, Verde E, and the Madrid Acute Renal Failure Study Group: The spectrum of acute renal failure in the intensive care unit compared with that seen in other settings. Kidney Int 1998;53:S16-S24.
3. Brivet FG, Kleinknecht DJ, Liorat P, Landais PJM: Acute renal failure in intensive care units causes, outcome, and prognostic factors of hospital mortality: A prospective, multicenter study. Crit Care Med 1996;24:192-198.
4. Morrison DC, Ulevitch RY: The effects of bacterial endotoxin on host mediator system. Am J Pathol 1987;93:527-617.
5. Glauser MP, Zanetti G, Baumgartner JD, Cohen J: Septic shock: Pathogenesis. Lancet 1991;338: 732-736.
6. Zeni F, Freeman B, Nathanson C: Anti-inflammatory therapies to treat sepsis and septic shock: A reassessment. Crit Care Med 1997;25:1095-1100.
7. Munoz C, Carlet J, Fitting C, Misset B, Bleriot JP, Cavaillon JM: Dysregulation of in vitro cytokine production by monocytes during sepsis. J Clin Invest 1991;88:1747-1754.
8. Randow F, Syrbe U, Meisel C, Krausch D, Zuckermann H, Platzer C, Volk HD: Mechanism of endotoxin desensitization: Involvement of interleukin-10 and transforming growth factor β. J Exp Med 1995;181:1887-1892.
9. Gutierrez-Ramos JC, Bluethmann H: Molecules and mechanisms operating in septic shock: Lessons from knockout mice. Immunol Today 1997;18:329-334.
10. Astiz M, Saha D, Lustrader D, Lin R, Rackow E: Monocyte response to bacterial toxins, expression of cell surface receptors, and release of anti-inflammatory cytokines during sepsis. J Lab Clin Med 1996;128:594-600.
11. Lonnemann G, Bechstein M, Linnenweber S, Burg M, Koch KM: Tumor necrosis factor-α during continuous high-flux hemodialysis in sepsis with acute renal failure. Kidney Int 1999;56(suppl 72): S84-S87.
12. Volk HD, Reinke P, Krausch D, Zuckermann H, Asadullah K, Mueller JM, Doecke WD, Kox WJ: Monocyte deactivation: Rationale for a new therapeutic strategy in sepsis. Intensive Care Med 1996;22(suppl 4):S474-S481.
13. Brandtzaeg P, Osnes L, Ovstebo R, Joo GB, Westvik AB, Kierulf P: Net inflammatory capacity of human septic shock plasma evaluated by a monocyte-based target cell assay: Identification of interleukin10 as a major functional deactivator of human monocytes. J Exp Med 1996;184:51-60.
14. Adib-Conquy M, Adrie C, Moine P, Asehnoune K, Fitting C, Pinsky MR, Dhainaut JF, Cavaillon JM: NF-κB expression in mononuclear cells of patients with sepsis resembles that observed in lipopolysaccharide tolerance. Am J Respir Crit Care Med 2000;162:1877-1883.
15. Bellomo R, Farmer M, Wright C, Parkin G, Boyce N: Treatment of sepsis-associated severe acute renal failure with continuous hemodiafiltration: Clinical experience and comparison with conventional dialysis. Blood Purif 1995;13:246-254
16. Silvester W, Bellomo R, Ronco C: Continuous versus intermittent renal replacement therapy in the critically ill; in Ronco C, Bellomo R (eds): Critical Care Nephrology. Dordrecht, Kluwer Academic, 1998, pp 1225-1238.
17. Hoffmann JN, Hartl WH, Deppisch R, Faist E, Jochum M, Inthorn D: Hemofiltration in human sepsis: Evidence for elimination of immunomodulatory substances. Kidney Int 1995;48:1563-1570.
18. Ronco C, Tetta A, Lupi E, Galloni MC, Bettini L, Sereni F, Mariano A, De Martino G, Montrucchio G, Camussi G, La Greca G: Removal of platelet-activating factor in experimental continuous arteriovenous hemofiltration. Crit Care Med 1995;23:99-107.
19. De Vriese A, Colardyn A, Philippe JI, Vanholder RC, De Sutter JH, Lameire N: Cytokine removal during continuous hemofiltration in septic patients. J Am Soc Nephrol 1999;10:846-853.
20. Grootendorst AF, Van Bommel EF, Van Leengoed LA, Nabuurs M, Bouman CS, Groeneveld AB: High volume hemofiltration improves right ventricular function in endotoxin-induced shock in the pig. Intensive Care Med 1992;18:235-240.
21. Bellomo R, Baldwin I, Cole L, Ronco C: Preliminary experience with high-volume hemofiltration in human septic shock. Kidney Int Suppl 1998;66:S182-S185.
22. Ronco C, Bellomo R, Homel P, Brendolan A, Dan M, Piccinni P, La Greca G: Effects of different doses in continuous veno-venous haemofiltration on outcomes of acute renal failure: A prospective randomised trial. Lancet 2000;356:26-30.
23. Berlot G, Tomasini A, Silvestri L, Gullo A: Plasmapheresis in the critically ill patient. Kidney Int Suppl 1998;66:S178-S181.
24. Hjorth V, Stenlund G: Plasmapheresis as part of the treatment for septic shock. Scand J Infect Dis 2000;32:511-514.
25. Reeves JH, Butt WW, Shann F, Layton JE, Stewart A, Waring PM: Continuous plasmafiltration in sepsis syndrome. Plasmafiltration in Sepsis Study Group. Crit Care Med 1999;27:2096-2104.
26. La Greca G, Brendolan A, Ghezzi PM, De Smet R, Tetta C, Gervasio R, Ronco C: The concept of sorbents in hemodialysis. Int J Artif Organs 1998;21:303-308.
27. Ronco C, Brendolan A, Dan M, Piccinni P, Bellomo R, De Nitti C, Inguaggiato P, Tetta C: Adsorption in sepsis. Kidney Int 2000;58(suppl 76):S148-S155.
28. Tetta C, Cavaillon JM, Schulze M, Ronco C, Ghezzi PM, Camussi G, Serra AM, Curti F, Lonnemann G: Removal of cytokines and activated complement components in an experimental model of continuous plasmafiltration coupled with sorbent adsorption. Nephrol Dial Transplant 1998;13: 1458-1464.
29. Tetta C, Gianotti L, Cavaillon JM, Wratten ML, Fini M, Braga M, Bisagni P, Giavaresi GL, Bolzani R, Giardino R: Coupled plasma filtration adsorption in a rabbit model of endotoxic shock. Crit Care Med 2000;28:1526-1533.
30. Brendolan A, Irone M, Digno A, Cioffi M, Piccinni P, Dan M, Tetta C, Ronco C: Coupled plasma filtration-adsorption technique (CPAT) in sepsis-associated acute renal failure (SA-ARF): hemodynamic effects (Abstract). J Am Soc Nephrol 1998;9:127A.